Clinical trial · Observational
Genomic Changes in Childhood Acute Lymphoblastic Leukemia
Genomics Evolution in Childhood Acute Lymphoblastic Leukemia
NCT01089907CI-TRIAL-00003283unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To study the genomics with cell cycle and lymphocyte differentiation in disease, remission and relapse of childhood acute lymphoblastic leukemia. Then correlate these data with age, white cell count, cytogenetic changes, response to the chemotherapy and prognosis.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acute Lymphoblastic Leukemia | Acute Lymphoblastic Leukemia | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 1 Day
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. patients diagnosed as acute lymphoblastic leukemia 2. age less than or equal to 18 years old 3. signed informed consent Exclusion Criteria: 1. who is not acute lymphoblastic leukemia 2. who did not sign informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.